New Drug Shows Promise in Reversing Skin Disease Associated with Systemic Sclerosis
According to a new study funded in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a new drug appears to alter the expression of certain genes associated with systemic sclerosis by blocking a key protein.
6 Things to Know About Massage Therapy for Health Purposes
There is a lot of scientific research on massage therapy and most of that research is preliminary or conflicting. On the bright side, much of the evidence points toward beneficial effects on pain and other symptoms associated with a number of different conditions.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.